SCWorx (WORX) Company Report

On September 17, 2025, SCWorx Corp. entered into warrant inducement agreements with holders of certain existing warrants.
Under these agreements, holders exercised existing warrants to purchase 2,064,000 shares of common stock at an exercise price of $0.3496 per share, resulting in aggregate gross proceeds of approximately $721,574 for the company.
In consideration, SCWorx Corp. agreed to issue new unregistered warrants to purchase an aggregate of 4,128,000 shares of common stock, which is equal to 200% of the shares issued from the exercise of existing warrants.
The new warrants will have an exercise price of $0.31004 per share and will be exercisable on or after the date of stockholder approval, with a term of exercise of five years from that date.
The company expects to use the net proceeds from these transactions for working capital and other general corporate purposes.

Sep 19, 2025, 8:15 PM

SCWorx Forms Strategic Healthcare Supply Chain Partnership

WORX

New Projects/Investments

SCWorx Corp. has announced a strategic partnership with a leading healthcare supply chain consulting firm to enhance its SaaS data management program and improve procurement efficiency for healthcare customers nationwide.
This collaboration leverages SCWorx's data cleanse, normalization, and enrichment services to support the partner in helping hospitals reduce costs and optimize spending through extensive purchasing power across all 50 states.
SCWorx's CEO, Tim Hannibal, highlighted that the partnership reinforces the company's unique value proposition in assisting U.S. hospitals with data utilization for cost savings and operational efficiency.
Financially, SCWorx has a market capitalization of approximately $3.62 million and reported revenue of $2.84 million, but it faces significant financial challenges with a negative operating margin (-49.35%), net margin (-105.74%), and EBITDA margin (-44.1%).

Aug 26, 2025, 3:08 PM

Get instant answers from SEC filings, earnings calls & more